Jonathan Graf
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease (NCT01893996) | Jonathan Graf | 2013-07-01 |
Track Jonathan Graf automatically
Every clearance here is in the API, with alerts when new ones post.